Dosage and administration
One softgel by mouth daily or as directed by a physician.
One softgel by mouth daily or as directed by a physician.
Other Ingredients: gelatin, glycerin, yellow bees wax, purified water, soy lecithin, natural cream orange flavor, titanium dioxide, ethyl vanillin, FD&C Red #40, FD&C Blue #1.
CONTAINS: SOY AND FISH (ANCHOVIES, MACKEREL, SARDINES, TUNA)
GLUTEN-, LACTOSE- AND SUGAR-FREE
OB Complete® One is a prescription multivitamin/multimineral indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and non-lactating mothers.
OB Complete® One should not be used by patients with a known hypersensitivity to any of the listed ingredients including soy and fish oil.
| WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately. |
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient. Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurologic manifestations remain progressive. Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
Biotin levels higher than the recommended daily allowance may cause interference with some laboratory tests, including cardiovascular diagnostic tests (e.g. troponin) and hormone tests, and may lead to incorrect test results. Tell your healthcare provider about all prescription and over-the-counter medicines, vitamins, and dietary supplements that you take, including biotin.
The patient’s medical conditions and consumption of other drugs, herbs, and/or supplements should be considered.
OB Complete® One softgels are not recommended for and should not be given to patients receiving levodopa because the action of levodopa is antagonized by pyridoxine. There is a possibility of increased bleeding due to pyridoxine interaction with anticoagulants (e.g., Aspirin, Heparin, Clopidogrel).
Adverse reactions have been reported with specific vitamins and minerals but generally at levels substantially higher than those contained herein. However, allergic and idiosyncratic reactions are possible at lower levels. Iron, even at the usual recommended levels, has been associated with gastrointestinal intolerance in some patients.
OB Complete® One is an oblong-shaped purple softgel, imprinted "VP044".
One softgel by mouth daily or as directed by a physician.
OB Complete® One is supplied in a carton of 30 capsules, packaged in 3 child resistant unit-dose blister cards of 10 softgels per card.
Product Code: 68025-044-30
Store at controlled room temperature 15°-30°C (59°-86°F) [See USP]. Protect from light, moisture and excessive heat.
KEEP THIS PRODUCT OUT OF REACH OF CHILDREN.
*DimaCal is a registered trademark of Albion International, Inc.
Malates covered by U.S. Patent No. 6,706,904.
**Sumalate® (Ferrous Asparto Glycinate) is a registered trademark of Albion International, Inc. and is covered by the following patents: U.S. Pat. No. 6,716,814; U.S. Pat. No. 8,007,846 and U.S. Pat. No. 8,425,956.
For use on the order of a healthcare practitioner.
Call your doctor about side effects. To report side effects, call Vertical Pharmaceuticals at 1-770-509-4500 or FDA at 1-800-FDA-1088 or
www.fda.gov/medwatch.
PLR-OBCO-00005-5 Rev. 04/2025
Distributed by:
Vertical Pharmaceuticals, LLC
Alpharetta, GA 30005

| Class | Version | Type | Effective |
|---|---|---|---|
| ASCORBIC ACID Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CALCIUM CATION Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20230427 |
| CHOLECALCIFEROL Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CYANOCOBALAMIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| MAGNESIUM CATION Pharmacologic Class Indexing | 4 | Indexing - Pharmacologic Class | 20180813 |
| PYRIDOXINE Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20170310 |
| ZINC CATION Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68025-044-30 | OB Complete One | 10 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 10 | 12 | |
| 68025-044-30 | OB Complete One | 3 in 1 CARTON | CAPSULE, LIQUID FILLED | 3 | 12 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68025-044-30 | EA - Each | 68025-044 | 1cf01ae3-2ff7-4297-967c-ce19e50f885b | 1 | 2013-05-02 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| .Alpha.-Tocopherol Acetate, D- | ACTIVE INGREDIENT | A7E6112E4N | 3 | |
| Biotin | ACTIVE INGREDIENT | 6SO6U10H04 | 3 | |
| Calcium Ascorbate | ACTIVE INGREDIENT | 183E4W213W | 3 | |
| Calcium Carbonate | ACTIVE INGREDIENT | H0G9379FGK | 3 | |
| Calcium L-Threonate | ACTIVE INGREDIENT | HBB4YPO93U | 3 | |
| Calcium Malate | ACTIVE INGREDIENT | D48OP746DW | 3 | |
| Cholecalciferol | ACTIVE INGREDIENT | 1C6V77QF41 | 3 | |
| Cupric Sulfate | ACTIVE INGREDIENT | LRX7AJ16DT | 3 | |
| Cyanocobalamin | ACTIVE INGREDIENT | P6YC3EG204 | 3 | |
| Doconexent | ACTIVE INGREDIENT | ZAD9OKH9JC | 3 | |
| Ferrous Asparto Glycinate | ACTIVE INGREDIENT | H7426RGB3L | 3 | |
| Fish Oil | ACTIVE INGREDIENT | XGF7L72M0F | 3 | |
| Folic Acid | ACTIVE INGREDIENT | 935E97BOY8 | 3 | |
| Icosapent | ACTIVE INGREDIENT | AAN7QOV9EA | 3 | |
| Iron | ACTIVE INGREDIENT | E1UOL152H7 | 3 | |
| Magnesium Oxide | ACTIVE INGREDIENT | 3A3U0GI71G | 3 | |
| Niacinamide | ACTIVE INGREDIENT | 25X51I8RD4 | 3 | |
| Potassium Iodide | ACTIVE INGREDIENT | 1C4QK22F9J | 3 | |
| Pyridoxine Hydrochloride | ACTIVE INGREDIENT | 68Y4CF58BV | 3 | |
| Riboflavin | ACTIVE INGREDIENT | TLM2976OFR | 3 | |
| Thiamine Mononitrate | ACTIVE INGREDIENT | 8K0I04919X | 3 | |
| Zinc Oxide | ACTIVE INGREDIENT | SOI2LOH54Z | 3 | |
| .Alpha.-Tocopherol, D- | ACTIVE MOIETY | N9PR3490H9 | 3 | |
| Ascorbic Acid | ACTIVE MOIETY | PQ6CK8PD0R | 3 | |
| Biotin | ACTIVE MOIETY | 6SO6U10H04 | 3 | |
| Calcium Cation | ACTIVE MOIETY | 2M83C4R6ZB | 3 | |
| Cholecalciferol | ACTIVE MOIETY | 1C6V77QF41 | 3 | |
| Cupric Cation | ACTIVE MOIETY | 8CBV67279L | 3 | |
| Cyanocobalamin | ACTIVE MOIETY | P6YC3EG204 | 3 | |
| Doconexent | ACTIVE MOIETY | ZAD9OKH9JC | 3 | |
| Ferrous Cation | ACTIVE MOIETY | GW89581OWR | 3 | |
| Fish Oil | ACTIVE MOIETY | XGF7L72M0F | 3 | |
| Folic Acid | ACTIVE MOIETY | 935E97BOY8 | 3 | |
| Icosapent | ACTIVE MOIETY | AAN7QOV9EA | 3 | |
| Iodide Ion | ACTIVE MOIETY | 09G4I6V86Q | 3 | |
| Iron | ACTIVE MOIETY | E1UOL152H7 | 3 | |
| Magnesium Cation | ACTIVE MOIETY | T6V3LHY838 | 3 | |
| Niacinamide | ACTIVE MOIETY | 25X51I8RD4 | 3 | |
| Pyridoxine | ACTIVE MOIETY | KV2JZ1BI6Z | 3 | |
| Riboflavin | ACTIVE MOIETY | TLM2976OFR | 3 | |
| Thiamine Ion | ACTIVE MOIETY | 4ABT0J945J | 3 | |
| Zinc Cation | ACTIVE MOIETY | 13S1S8SF37 | 3 | |
| Ethyl Vanillin | INACTIVE INGREDIENT | YC9ST449YJ | 3 | |
| FD&C Blue NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | 3 | |
| FD&C Red NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | 3 | |
| Gelatin | INACTIVE INGREDIENT | 2G86QN327L | 3 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 3 | |
| Lecithin, Soybean | INACTIVE INGREDIENT | 1DI56QDM62 | 3 | |
| Orange Oil | INACTIVE INGREDIENT | AKN3KSD11B | 3 | |
| Soybean Oil | INACTIVE INGREDIENT | 241ATL177A | 3 | |
| Titanium Dioxide | INACTIVE INGREDIENT | 15FIX9V2JP | 3 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 3 | |
| Yellow Wax | INACTIVE INGREDIENT | 2ZA36H0S2V | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 68025-044 | 68025-044-30 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| FD&C Blue NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | TABLET / ORAL | 27.53 mg | ||
| Gelatin | GELATIN | 2G86QN327L | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 14 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | INSERT, EXTENDED RELEASE / OPHTHALMIC | 0.4 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | PASTE / DENTAL | 0.5 %w/w | ||
| Gelatin | GELATIN | 2G86QN327L | INJECTION, SUSPENSION / INTRAMUSCULAR | 1.3 mg | ||
| Yellow Wax | YELLOW WAX | 2ZA36H0S2V | CAPSULE, EXTENDED RELEASE / ORAL | 80.67 mg | ||
| Soybean Oil | SOYBEAN OIL | 241ATL177A | CAPSULE / ORAL | 1318 mg | ||
| FD&C Red NO. 40 | FD&C RED NO. 40 | WZB9127XOA | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| FD&C Blue NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | LIQUID / ORAL | NA | ||
| Yellow Wax | YELLOW WAX | 2ZA36H0S2V | CREAM / TOPICAL | 5 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| FD&C Blue NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | TABLET, EXTENDED RELEASE / ORAL | 4 mg | ||
| FD&C Blue NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | CAPSULE, DELAYED RELEASE / ORAL | 2 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | GUM, CHEWING / BUCCAL | 182 mg | ||
| FD&C Blue NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | TABLET, DELAYED RELEASE / ORAL | 0.01 mg | ||
| Gelatin | GELATIN | 2G86QN327L | TABLET / SUBLINGUAL | 19 mg | ||
| FD&C Red NO. 40 | FD&C RED NO. 40 | WZB9127XOA | POWDER, FOR SOLUTION / ORAL | 0.33 mg/5ml | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | POWDER, FOR SUSPENSION / ORAL | 297 mg | ||
| Yellow Wax | YELLOW WAX | 2ZA36H0S2V | CAPSULE / ORAL | 44 mg | ||
| Ethyl Vanillin | ETHYL VANILLIN | YC9ST449YJ | PASTE / ORAL | 7 mg | ||
| FD&C Blue NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | SOLUTION / RECTAL | 0.01 %w/v | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | TABLET, COATED / ORAL | 49 mg | ||
| Gelatin | GELATIN | 2G86QN327L | TABLET, EXTENDED RELEASE / ORAL | 239 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| Yellow Wax | YELLOW WAX | 2ZA36H0S2V | TABLET / ORAL | 3.22 mg | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | SOAP / TOPICAL | 1 %w/w | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | CAPSULE, DELAYED RELEASE / ORAL | 55 mg | ||
| Lecithin, Soybean | SOYBEAN LECITHIN | 1DI56QDM62 | AEROSOL, METERED / RESPIRATORY (INHALATION) | 0.1 %w/w | ||
| Titanium Dioxide | TITANIUM DIOXIDE | 15FIX9V2JP | GEL / TOPICAL | 0.06 %w/w | ||
| FD&C Red NO. 40 | FD&C RED NO. 40 | WZB9127XOA | GUM, CHEWING / BUCCAL | 48 mg | ||
| Orange Oil | ORANGE OIL, COLD PRESSED | AKN3KSD11B | TABLET, CHEWABLE / ORAL | 3.7 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| Yellow Wax | YELLOW WAX | 2ZA36H0S2V | TABLET, EXTENDED RELEASE / ORAL | 0.01 mg | ||
| FD&C Blue NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | CAPSULE, LIQUID FILLED / ORAL | 0.08 mg | ||
| Orange Oil | ORANGE OIL, COLD PRESSED | AKN3KSD11B | ELIXIR / ORAL | 0.24 mg | ||
| Gelatin | GELATIN | 2G86QN327L | TABLET, ORALLY DISINTEGRATING / SUBLINGUAL | 13 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| FD&C Blue NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | LIQUID / TOPICAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| FD&C Blue NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | FILM, SOLUBLE / ORAL | 0.04 mg | ||
| Gelatin | GELATIN | 2G86QN327L | INJECTION / INTRACAVITARY | 0.05 ml | ||
| FD&C Red NO. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET, CHEWABLE / ORAL | 40 mg | ||
| Gelatin | GELATIN | 2G86QN327L | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 14 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | OINTMENT / TOPICAL | NA | ||
| Gelatin | GELATIN | 2G86QN327L | SUPPOSITORY / VAGINAL | NA | ||
| Gelatin | GELATIN | 2G86QN327L | INJECTION, POWDER, FOR SUSPENSION / INTRAMUSCULAR | 2 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| Lecithin, Soybean | SOYBEAN LECITHIN | 1DI56QDM62 | CREAM / VAGINAL | 1 %w/w | ||
| FD&C Red NO. 40 | FD&C RED NO. 40 | WZB9127XOA | TABLET, FILM COATED / ORAL | 2.5 mg | ||
| FD&C Blue NO. 1 | FD&C BLUE NO. 1 | H3R47K3TBD | TABLET, COATED / ORAL | 0.52 mg | ||
| Gelatin | GELATIN | 2G86QN327L | POWDER / RESPIRATORY (INHALATION) | 100 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOAP / TOPICAL | 0.76 %w/w | ||
| Gelatin | GELATIN | 2G86QN327L | INJECTION / INTRAVENOUS | 20 mg | ||
| Gelatin | GELATIN | 2G86QN327L | CAPSULE, LIQUID FILLED / ORAL | 1042 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Omegaven | FISH OIL | Fresenius Kabi USA, LLC | 5d9d0b24-e139-48bf-ab2d-536fb59cf8e0 | 2025-09-05 | Warnings, Adverse reactions | FISH OIL |